泽璟制药-U上涨5% 生物医药论坛召开

智选洞察10:01

11月20日，泽璟制药-U（688266）股价大幅上涨，截至10点01分，泽璟制药-U上涨5.02%，报65.64元/股，成交8450万元，换手率0.50%，振幅5.66%。消息解读近日，2024 第二届浦江生物医药源头创新论坛在浦东召开，此次论坛聚焦我国医药工业前沿技术创新与全球医药合作等热点议题。《上海市宝山区生物医药产业合规指引》也正式发布，这是上海首部生物医药产业合规指引。此外，数据统计...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2484806133?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-20 10:01","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2484806133","market":"sh","top_or_hot":-1,"title":"泽璟制药-U上涨5% 生物医药论坛召开","media":"智选洞察","content":"<div>\n<p>11月20日，泽璟制药-U（688266）股价大幅上涨，截至10点01分，泽璟制药-U上涨5.02%，报65.64元/股，成交8450万元，换手率0.50%，振幅5.66%。消息解读近日，2024 第二届浦江生物医药源头创新论坛在浦东召开，此次论坛聚焦我国医药工业前沿技术创新与全球医药合作等热点议题。《上海市宝山区生物医药产业合规指引》也正式发布，这是上海首部生物医药产业合规指引。此外，数据统计...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100129a24735fb&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>泽璟制药-U上涨5% 生物医药论坛召开</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n泽璟制药-U上涨5% 生物医药论坛召开\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 10:01 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100129a24735fb&s=b><strong>智选洞察</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>11月20日，泽璟制药-U（688266）股价大幅上涨，截至10点01分，泽璟制药-U上涨5.02%，报65.64元/股，成交8450万元，换手率0.50%，振幅5.66%。消息解读近日，2024 第二届浦江生物医药源头创新论坛在浦东召开，此次论坛聚焦我国医药工业前沿技术创新与全球医药合作等热点议题。《上海市宝山区生物医药产业合规指引》也正式发布，这是上海首部生物医药产业合规指引。此外，数据统计...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100129a24735fb&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"688266","symbol_name":"泽璟制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100129a24735fb&s=b","article_id":"2484806133","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120100129a24735fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2484806133","pubTimestamp":1732068074,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"11月20日，泽璟制药-U股价大幅上涨，截至10点01分，泽璟制药-U上涨5.02%，报65.64元/股，成交8450万元，换手率0.50%，振幅5.66%。资金动向截止发稿，泽璟制药-U获得主力净流入422万元，其中超大单流入33万元，大单流入389万元。主营业务及业绩泽璟制药-U公司主营业务为化学新药及生物新药的研发、生产及销售。最新财报显示，今年三季报，泽璟制药-U实现营业收入3.84亿元，同比增长36.16%，净利润为-9,790.30万元，同比增长51.55%，基本每股收益为-0.37元。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"161726":"生物医药","399441":"生物医药","688266":"泽璟制药","BK0239":"医药制造"},"translate_title":"Zejing Pharmaceutical-U rose 5%, biomedical forum held","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"161726":1,"399441":1,"688266":1},"content_text":"11月20日，泽璟制药-U（688266）股价大幅上涨，截至10点01分，泽璟制药-U上涨5.02%，报65.64元/股，成交8450万元，换手率0.50%，振幅5.66%。消息解读近日，2024 第二届浦江生物医药源头创新论坛在浦东召开，此次论坛聚焦我国医药工业前沿技术创新与全球医药合作等热点议题。《上海市宝山区生物医药产业合规指引》也正式发布，这是上海首部生物医药产业合规指引。此外，数据统计显示，近半年内2家券商给予增持建议，14家券商给予买入建议。资金动向截止发稿，泽璟制药-U获得主力净流入422万元，其中超大单流入33万元，大单流入389万元。数据显示，该股今日净流入较近5日净流入均值增加33万元。主营业务及业绩泽璟制药-U公司主营业务为化学新药及生物新药的研发、生产及销售。最新财报显示，今年三季报，泽璟制药-U实现营业收入3.84亿元，同比增长36.16%，净利润为-9,790.30万元，同比增长51.55%，基本每股收益为-0.37元。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"Important Conferences","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484806133"}